Inhibrx Biosciences Inc. (INBX)
13.66
0.41 (3.09%)
At close: Mar 03, 2025, 12:38 PM
Inhibrx Biosciences Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Revenue | 1.8M | 2.18M | 7.13M | 12.81M | 9.09M | 7.5M | 7.95M | 6.67M |
| Cost of Revenue | 1.19M | 2.85M | 2.69M | 73.5M | 47.91M | 33.45M | 25.51M | 16.99M |
| Gross Profit | 609K | -668K | 4.44M | -60.69M | -38.81M | -25.95M | -17.56M | -10.32M |
| Operating Income | -219.22M | -129.12M | -76.56M | -67.44M | -43.71M | -29.51M | -19.73M | -12.15M |
| Interest Income | 11.92M | 16.11M | 5.22M | 10.82M | 5.72M | n/a | n/a | 759K |
| Pretax Income | -239.72M | -145.22M | -81.77M | -75.63M | -50.5M | -30.93M | -21.83M | -12.88M |
| Net Income | -241.36M | -145.23M | -81.77M | -75.64M | -51.4M | -31.16M | -19.44M | -8.27M |
| Selling & General & Admin | 29.38M | 21.12M | 12.36M | 6.84M | 9.02M | 4.65M | 2.61M | 1.57M |
| Research & Development | 190.65M | 110.19M | 71.44M | 73.5M | 47.91M | 33.45M | 25.51M | 16.99M |
| Other Expenses | n/a | -14K | -106K | -80K | -4.12M | 68K | 24K | n/a |
| Operating Expenses | 219.83M | 131.29M | 83.69M | 80.25M | 52.81M | 37.01M | 27.68M | 18.56M |
| Interest Expense | 31.84M | 16.11M | 5.22M | 10.82M | 5.72M | 1.48M | 2.13M | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -253K |
| Cost & Expenses | 221.02M | 131.29M | 83.69M | 80.25M | 52.81M | 37.01M | 27.68M | 18.81M |
| Income Tax | 3K | 3K | 2K | 3K | 898K | 96K | 250K | -4.62M |
| Shares Outstanding (Basic) | 47.13M | 40.11M | 38.01M | 25.26M | 36.55M | 27.08M | 28.79M | 36.55M |
| Shares Outstanding (Diluted) | 47.13M | 40.11M | 38.01M | 25.26M | 36.55M | 27.08M | 28.79M | 36.55M |
| EPS (Basic) | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| EPS (Diluted) | -5.12 | -3.62 | -2.15 | -2.99 | -1.41 | -1.15 | -0.68 | -0.23 |
| EBITDA | -206.69M | -125.82M | -76.56M | -67.44M | -42.6M | -28.77M | -19.3M | -11.89M |
| Depreciation & Amortization | 1.19M | 1.23M | 2.69M | 2.39M | 2.52M | 676K | 399K | 253K |